Nothing Special   »   [go: up one dir, main page]

FI963989A - Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon - Google Patents

Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon Download PDF

Info

Publication number
FI963989A
FI963989A FI963989A FI963989A FI963989A FI 963989 A FI963989 A FI 963989A FI 963989 A FI963989 A FI 963989A FI 963989 A FI963989 A FI 963989A FI 963989 A FI963989 A FI 963989A
Authority
FI
Finland
Prior art keywords
transmission
determination based
luminescence energy
homogeneous methods
homogeneous
Prior art date
Application number
FI963989A
Other languages
English (en)
Swedish (sv)
Other versions
FI963989A0 (fi
Inventor
Ilkka Antero Hemmilae
Pertti Juhani Hurskainen
Kaj Runar Blomberg
Veli-Matti Mukkala
Harri Juhani Takalo
Satu Anneli Kovanen
Stuart Alan Webb
Original Assignee
Wallac Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallac Oy filed Critical Wallac Oy
Priority to FI963989A priority Critical patent/FI963989A/fi
Publication of FI963989A0 publication Critical patent/FI963989A0/fi
Priority to JP10517208A priority patent/JP2001502055A/ja
Priority to EP97919087A priority patent/EP0929810A2/en
Priority to PCT/FI1997/000560 priority patent/WO1998015830A2/en
Publication of FI963989A publication Critical patent/FI963989A/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6408—Fluorescence; Phosphorescence with measurement of decay time, time resolved fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G01N2021/6441—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/40—Rare earth chelates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI963989A 1996-10-04 1996-10-04 Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon FI963989A (fi)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FI963989A FI963989A (fi) 1996-10-04 1996-10-04 Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon
JP10517208A JP2001502055A (ja) 1996-10-04 1997-09-19 ホモジニアスルミネセンスエネルギー転移アッセイ
EP97919087A EP0929810A2 (en) 1996-10-04 1997-09-19 Homogenous luminescence energy transfer assays
PCT/FI1997/000560 WO1998015830A2 (en) 1996-10-04 1997-09-19 Homogenous luminescence energy transfer assays

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI963989A FI963989A (fi) 1996-10-04 1996-10-04 Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon

Publications (2)

Publication Number Publication Date
FI963989A0 FI963989A0 (fi) 1996-10-04
FI963989A true FI963989A (fi) 1998-04-05

Family

ID=8546810

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963989A FI963989A (fi) 1996-10-04 1996-10-04 Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon

Country Status (4)

Country Link
EP (1) EP0929810A2 (fi)
JP (1) JP2001502055A (fi)
FI (1) FI963989A (fi)
WO (1) WO1998015830A2 (fi)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998146A (en) * 1998-07-17 1999-12-07 Wallac Oy Homogeneous luminescence assay method based on energy transfer
WO2000039335A1 (en) * 1998-12-24 2000-07-06 Aclara Biosciences, Inc. Individually addressable solid surfaces for multiplexed operations
FR2792072A1 (fr) * 1999-04-08 2000-10-13 Cis Bio Int Methode homogene de detection ou de determination d'une interaction chimique ou physicochimique
EP1238285A1 (en) * 1999-11-30 2002-09-11 Akzo Nobel N.V. Steroid compounds for steroid receptor binding assays
JP2001255326A (ja) * 2000-01-31 2001-09-21 Pen State Res Found:The 密封容器の内容物の変化についての問合わせ
FI20000333A0 (fi) 2000-02-16 2000-02-16 Jussi Nurmi Homogeeninen menetelmä polynukleotidin havaitsemiseksi
US7771929B2 (en) 2000-04-28 2010-08-10 Monogram Biosciences, Inc. Tag library compounds, compositions, kits and methods of use
US7160735B2 (en) 2000-04-28 2007-01-09 Monogram Biosciences, Inc. Tagged microparticle compositions and methods
FR2809817B1 (fr) 2000-06-02 2003-08-15 Cis Bio Int Procede de detection de presence d'un liquide dans un melange
DE10058596A1 (de) * 2000-11-25 2002-06-06 Aventis Pharma Gmbh Verfahren zum Screening von chemischen Verbindungen zur Modulierung der Wechselwirkung einer EVH1-Domäne oder eines Proteins mit einer EVH1-Domäne mit einer EVH1-Bindedomäne oder einem Protein mit einer EVH1-Bindedomäne sowie ein Verfahren zum Nachweis besagter Wechselwirkung
EP1382965B1 (en) * 2001-04-23 2005-11-30 Eiken Kagaku Kabushiki Kaisha Analysis method using reporter (label) intermolecular interaction
CA2445053A1 (en) 2001-05-21 2002-11-28 Aclara Biosciences, Inc. Methods and compositions for analyzing proteins
AU2002305658A1 (en) 2001-05-21 2002-12-03 Aclara Biosciences, Inc. Analyzing phosphorylated proteins
AU2002344221A1 (en) 2001-05-26 2002-12-09 Aclara Biosciences, Inc. Catalytic amplification of multiplexed assay signals
US7211440B2 (en) 2002-03-08 2007-05-01 Wallac Oy Dissociative fluorescence enhancement assay
US20040229294A1 (en) 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB surface receptor complexes as biomarkers
US7524974B2 (en) 2002-07-08 2009-04-28 Tetsuo Nagano Fluorescent probe
DE602004008243T2 (de) * 2003-03-28 2008-05-15 Tero Soukka Homogenes Bioassay-Verfahren auf der Basis von Lumineszenzenergietransfer
FI20030460A0 (fi) 2003-03-28 2003-03-28 Tero Soukka Homogeeninen määritysmenetelmä, joka perustuu luminesenssienergiasiirtoon
US7696245B2 (en) 2003-03-28 2010-04-13 Sekisui Medical Co., Ltd. Fluorescent probe for zinc
ATE403870T1 (de) * 2003-10-01 2008-08-15 Wallac Oy Verbesserter homogenener zeitaufgelöster energietransfertest
EP1695083A1 (de) 2003-12-01 2006-08-30 Dade Behring Marburg GmbH Homogenes nachweisverfahren
JP2005194244A (ja) 2004-01-09 2005-07-21 Shigenobu Yano 亜鉛イオン蛍光センサー
GB2433993B (en) * 2004-10-19 2010-04-28 Wallac Oy Single molecule TR-FRET probe
DE112005002636T5 (de) * 2004-10-22 2007-09-06 Wallac Oy Hochempfindliche homogene Analyse auf der Grundlage einer FRET-Messung mit Anti-Stokes-Verschiebung
JP4683572B2 (ja) * 2005-01-28 2011-05-18 塩野義製薬株式会社 組換え蛋白質の定量法
US7826052B2 (en) 2005-05-24 2010-11-02 Hidex Oy Correction method and measurement device for anti-stokes photoluminescence measurement
EP1994407A4 (en) 2005-12-30 2009-05-20 Turun Yliopisto METHOD FOR DETERMINING THE CONCENTRATION, LOAD OR SIZE UNIT OF A SUBSTANCE
JPWO2007125822A1 (ja) * 2006-04-28 2009-09-10 国立大学法人東京工業大学 薬剤スクリーニングのための複合体
EP1933151A1 (en) 2006-12-15 2008-06-18 F. Hoffmann-La Roche Ag Assays for measuring phosphate modification enzyme activity
EP2053059A1 (en) 2007-10-26 2009-04-29 Sanofi-Aventis Complexes of TRPC domains and SESTD1 domains and methods and uses involving the same
WO2010063652A1 (en) 2008-12-04 2010-06-10 Sanofi-Aventis Methods and uses involving heme binding protein 1
EP2226633A1 (en) 2009-03-06 2010-09-08 Charité - Universitätsmedizin Berlin Uses and methods for the identification of a cytoprotective compound involving gp130 or LIFRalpha
CA2759885A1 (fr) * 2009-04-30 2010-11-04 Etienne Doumazane Procede de detection de composes modulateurs de dimeres de proteines membranaires a domaine vft
EP2267152A1 (en) 2009-06-26 2010-12-29 Sanofi-Aventis Test system for measuring MEST activity as well as methods and uses involving the same
EP2320236A1 (en) 2009-11-06 2011-05-11 Sanofi-aventis Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2348129A1 (en) 2010-01-21 2011-07-27 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2348128A1 (en) 2010-01-21 2011-07-27 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2348130A1 (en) 2010-01-21 2011-07-27 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
US8673823B2 (en) 2010-03-18 2014-03-18 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2547789B1 (en) 2010-03-18 2015-07-22 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
WO2011113891A1 (en) 2010-03-18 2011-09-22 Sanofi-Aventis Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2390349A1 (en) 2010-05-25 2011-11-30 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2390348A1 (en) 2010-05-25 2011-11-30 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2532755A1 (en) 2011-06-10 2012-12-12 Sanofi-Aventis Methods and uses based on Slfn2 expression and relating to the identification and profiling of compounds for use in the treatment or prevention of pain
CN102353790B (zh) * 2011-06-25 2014-03-05 南方医科大学 一种甲胎蛋白的均相时间分辨荧光分析方法
WO2013188927A1 (en) 2012-06-22 2013-12-27 Macquarie University Multiplex suspension assay/array using lifetime coding
US9736555B2 (en) 2013-04-15 2017-08-15 Wallac Oy Method and a device for cross-talk correction of measured intensities
CN104181310A (zh) * 2014-07-30 2014-12-03 美艾利尔（上海）诊断产品有限公司 一种检测β-hCG含量的时间分辨免疫荧光试剂盒及其制备方法和应用
WO2019055661A1 (en) 2017-09-13 2019-03-21 Progenity, Inc. PRE-ÉCLAMPSIE BIOMARKERS AND ASSOCIATED SYSTEMS AND METHODS
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS
FI130554B (fi) 2020-01-20 2023-11-16 Oy Arctic Partners Ab Luminesenssi hybridisaatiomääritysmenetelmä

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996143A (en) * 1985-12-23 1991-02-26 Syngene, Inc. Fluorescent stokes shift probes for polynucleotide hybridization
US4868103A (en) * 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
JP2802921B2 (ja) * 1986-06-17 1998-09-24 マイクロスキャン、インコーポレイテッド 蛍光バックグラウンド消去および水溶性希土類金属キレートフルオロフォルを使用する均質蛍光アッセイ
US5194300A (en) * 1987-07-15 1993-03-16 Cheung Sau W Methods of making fluorescent microspheres
GB8820887D0 (en) * 1988-09-06 1988-10-05 Atomic Energy Authority Uk Detecting selected species
US5326692B1 (en) * 1992-05-13 1996-04-30 Molecular Probes Inc Fluorescent microparticles with controllable enhanced stokes shift
FR2664699B1 (fr) * 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
FR2664702B1 (fr) * 1990-07-13 1993-08-06 Cis Bio Int Procede de reduction d'interferences dans un dosage par fluorescence.
US5457186A (en) * 1993-10-13 1995-10-10 Wallac Oy Luminescent lanthanide chelates with decreased non-radiative energy loss
US5622821A (en) * 1994-06-29 1997-04-22 The Regents Of The University Of California Luminescent lanthanide chelates and methods of use
FI96367C (fi) * 1994-10-17 1996-06-10 Erkki Juhani Soini Biospecifinen määritysmenetelmä
US5741657A (en) * 1995-03-20 1998-04-21 The Regents Of The University Of California Fluorogenic substrates for β-lactamase and methods of use

Also Published As

Publication number Publication date
JP2001502055A (ja) 2001-02-13
FI963989A0 (fi) 1996-10-04
EP0929810A2 (en) 1999-07-21
WO1998015830A3 (en) 1998-06-18
WO1998015830A2 (en) 1998-04-16

Similar Documents

Publication Publication Date Title
FI963989A (fi) Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon
DE69718350D1 (de) Getriebe
DE69701776D1 (de) Getriebe
DE59700230D1 (de) Planetengetriebe
DE69902414D1 (de) Effiziente sichere Mehrfachübertragung mit minimaler Kenntnis
DE59709784D1 (de) Optoelektronische sendebaugruppe
DE69734180D1 (de) Spread-Spektrum-Empfänger
DE69707685D1 (de) Getriebe
DE69834358D1 (de) Leistungsübertragungseinheit
DE69735831D1 (de) Spread-Spektrum-Empfänger
DE59703512D1 (de) Getriebe
NL1007218A1 (nl) Drijfwerk.
DE69729350D1 (de) Spreizspektrumnachtrichtenübertragungssystem mit mitgesendeter Referenz
DE59707703D1 (de) Hydrodynamische Kupplung
DE59804725D1 (de) Erhöhung der spontanität eines automatgetriebes
NL1005465A1 (nl) Draaimomentbegrenzings-koppeling.
DE59802643D1 (de) Erhöhung der spontanität eines automatgetriebes
DE69711539D1 (de) Mehrgängiges Handschaltgetriebe
DE69738835D1 (de) Multicode CDMA Sender
FR2749360B1 (fr) Embrayage unidirectionnel
FR2757233B1 (fr) Embrayage unidirectionnel
DE59701327D1 (de) Automatisch steuerbare kupplung
DE59704209D1 (de) Erhöhung der spontanität eines automatgetriebes
DE19781582T1 (de) Leistungsübertragungsanordnung
DE59800270D1 (de) Erhöhung der spontaneität eines automatgetriebes